4592 Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices 

ACTION: Notice of Open Meeting. 

SUMMARY: The Advisory Committee on 

Rules of Evidence will hold a one-day 

meeting. The meeting will be open to 

public observation but not participation. 

DATES: April 17, 2015. 

Time: 8:30 a.m. to 5:00 p.m. 

ADDRESSES: Fordham University, School 

of Law, 150 West 62nd Street, New 

York, New York 10023. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan C. Rose, Rules Committee 

Secretary, Rules Committee Support 

Office, Administrative Office of the 

United States Courts, Washington, DC 

20544, telephone (202) 502–1820. 

Dated: January 23, 2015. 

Jonathan C. Rose, 

Rules Committee Secretary. 

[FR Doc. 2015–01565 Filed 1–27–15; 8:45 am] 

BILLING CODE 2210–55–P 

JUDICIAL CONFERENCE OF THE 

UNITED STATES 

Meeting of the Judicial Conference 

Committee on Rules of Practice and 

Procedure 

AGENCY: Judicial Conference of the 

United States, Advisory Committee on 

Rules of Criminal Procedure. 

ACTION: Notice of open meeting. 

SUMMARY: The Advisory Committee on 

Rules of Criminal Procedure will hold a 

two-day meeting. The meeting will be 

open to public observation but not 

participation. 

DATES: March 16–17, 2015. 

Time: 8:30 a.m. to 5 p.m. 

ADDRESSES: Florida A&M University, 

College of Law, 201 Beggs Avenue, 

Orlando, Florida 32801. 

FOR FURTHER INFORMATION CONTACT: 

Jonathan C. Rose, Rules Committee 

Secretary, Rules Committee Support 

Office, Administrative Office of the 

United States Courts, Washington, DC 

20544, telephone (202) 502–1820. 

Dated: January 23, 2015. 

Jonathan C. Rose, 

Rules Committee Secretary. 

[FR Doc. 2015–01564 Filed 1–27–15; 8:45 am] 

BILLING CODE 2210–55–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: 

MALLINCKRODT LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.33(a) on 

or before March 30, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart, R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on May 20, 

2014, Mallinckrodt LLC, 3600 North 

Second Street, St. Louis, Missouri 

63147, applied to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Controlled substance Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Lisdexamfetamine (1205) ............. II 

The company plans to manufacturer 

bulk active pharmaceutical ingredients 

(API) for distribution and product 

development to its customers. 

Dated: January 21, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01576 Filed 1–27–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Cambrex Charles City 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before February 27, 2015. Such 

persons may also file a written request 

for a hearing on the application 

pursuant to 21 CFR 1301.43 on or before 

February 27, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Comments and requests for 

hearings on applications to import 

narcotic raw materials are not 

appropriate. 72 FR 3417 (January 25, 

2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on May 15, 

2014, Cambrex Charles City, 1205 11th 

Street, Charles City, Iowa 50616–3466, 

applied to be registered as an importer 

of the following basic classes of 

controlled substances: 

mstockstill on DSK4VPTVN1PROD with NOTICES